VENLO, THE NETHERLANDS--(Marketwire - January 28, 2008) - QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced the launch of QIAsymphony® SP, the first system of the novel modular platform QIAsymphony which offers laboratories a new level of flexibility, convenience and safety in automated processing of a broad range of molecular sample and assay applications. With QIAsymphony SP, QIAGEN is launching the first module in its new series of modular instruments which can be integrated to automate entire workflows -- from sample to result. The QIAsymphony is the result of the largest development program ever undertaken at QIAGEN. The system is currently designed to meet users’ needs in the areas of applied testing, pharmaceutical and life science research. Following the validations and filings required in the respective countries, QIAGEN will further expand the use of the platform into the molecular diagnostics market.
